Lipid Lowering

Last updated: January 17, 2023
Sponsor: N/A
Overall Status: Active - Recruiting

Phase

N/A

Condition

High Cholesterol (Hyperlipidemia)

Treatment

N/A

Clinical Study ID

TX310317
  • Ages 40-100
  • All Genders

Study Summary

We are seeking participants for a clinical research study who have Cardiovascular Disease (history of heart attack, stroke, or symptomatic blockage in the arteries of the lower extremities). This study is designed to evaluate the treatment of an investigational medication along with a well- tolerated statin therapy (lipid lowering medication). The goal is to help reduce the risks of Cardiovascular Disease such as heart attacks and strokes.

Eligibility Criteria

Inclusion

Inclusion Criteria

  • .40 years of age and older
  • Have had a heart attack, stroke, or symptomatic blockage in the arteries of the lower extremities
  • Must be on a well-tolerated statin therapy
  • Additional qualification criteria exist

Study Design

Study Start date:
January 12, 2023
Estimated Completion Date:

Study Description

  • Reimbursement for travel and expenses
  • You are provided study-related care and study medicine (no health insurance required)
  • You may help make a difference for yourself and for people like you

Connect with a study center

  • Chase Medical Research, LLC

    Waterbury, Connecticut 06708
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.